¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : À¯Çüº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)
Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Distribution Channel, and Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1625477
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 118 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,149,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,596,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 27¾ï 3,324¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

³­¼Ò¾Ï, Æó¾Ï, ´ëÀå¾Ï µî È¿°úÀûÀÎ È­Çпä¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â ´Ù¾çÇÑ ¾ÏÀÇ À¯º´·ü Áõ°¡°¡ ¹é±Ý°è Ç×¾ÏÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎÀ¸·Î´Â °íÇü¾Ï Ä¡·á¿¡¼­ ½Ã½ºÇöóƾ, Ä«º¸Çöóƾ, ¿Á»ì¸®ÇÃ¶óÆ¾°ú °°Àº ¹é±Ý°è ¾à¹°ÀÇ Áö¼ÓÀûÀÎ È¿°ú, Ä¡·á ¼ºÀûÀ» Çâ»ó½ÃŰ´Â º´¿ë¿ä¹ý ¹× ¸ÂÃãÀÇ·áÀÇ ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù. ¾Ï Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ°í ÀÖ´Â ½ÅÈï±¹ ½ÃÀå°ú ºÎÀÛ¿ëÀ» ÁÙÀÌ°í ¾à¹°Àü´ÞÀ» °³¼±ÇÑ »õ·Î¿î Á¦Á¦ °³¹ß¿¡µµ ºñÁî´Ï½º ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù.

º´¿ë¿ä¹ýÀÇ ºÎ»ó, µ¶¼º °¨¼Ò¿¡ ´ëÇÑ °ü½É, ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ÀÇ Á¦³×¸¯ ÀǾàǰÀÇ Áõ°¡ µî ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå µ¿ÇâÀº ¿¹Ãø ±â°£ µ¿¾È Àüü ½ÃÀå È®´ë¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¹é±Ý Á¦Á¦ÀÇ »õ·Î¿î ¿ëµµ¸¦ ã±â À§ÇÑ ¿¬±¸°¡ ÁøÇàµÊ¿¡ µû¶ó ¹é±Ý Á¦Á¦ ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÏ¿© ´õ ³ªÀº ¾Ï Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä¿Í Àú·ÅÇÑ Ä¡·áÁ¦¿¡ ´ëÇÑ Àü ¼¼°è ¼ö¿ä¸¦ ÃæÁ·½Ãų °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

À¯Çüº°·Î´Â ½Ã½ºÇöóƾÀÌ ³­¼Ò¾Ï, °íȯ¾Ï µî ´Ù¾çÇÑ ¾Ï Ä¡·á¿¡ ¿À·£ ±â°£ »ç¿ëµÇ¾î È¿°úÀûÀ̱⠶§¹®¿¡ ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå Á¡À¯À²À» µ¶½ÄÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ´ëÀå¾Ï Ä¡·á ¹× º´¿ë¿ä¹ý¿¡ Àû¿ëÀÌ ÁøÇàµÇ°í ÀÖ´Â ¿Á»ì¸®ÇÃ¶óÆ¾ ºÎ¹®ÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

³­¼Ò¾ÏÀº ½Ã½ºÇöóƾ, Ä«º¸ÇÃ¶óÆ¾°ú °°Àº ¹é±Ý Á¦Á¦ÀÇ ³ôÀº Ä¡·á È¿°ú·Î ÀÎÇØ ¿ëµµº° ½ÃÀå Á¡À¯À²ÀÌ °¡Àå Å« ºÐ¾ßÀÔ´Ï´Ù. Æó¾ÏÀº ºñ¼Ò¼¼Æ÷Æó¾ÏÀÇ ¹ßº´·ü Áõ°¡¿Í ¹é±Ý Á¦Á¦¿Í ´Ù¸¥ ¾à¹°ÀÇ º´¿ëÅõ¿©·Î ÀÎÇØ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â ºÐ¾ßÀÔ´Ï´Ù.

À¯Åë ä³Îº°·Î´Â ÀÔ¿ø Ä¡·á ¹× ¾Ï Ä¡·á¿¡¼­ ¹é±ÝÁ¦Á¦¸¦ Æ÷ÇÔÇÑ È­Çпä¹ýÁ¦ÀÇ ÁÖ¿ä °ø±ÞóÀÎ º´¿ø ³» ¾à±¹ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¿Â¶óÀÎ ¾à±¹Àº ¿ø°ÝÀÇ·á¿Í ó¹æÀü º¸Ãæ ¹× ¿Ü·¡ Ä¡·á¿¡¼­ ȯÀÚÀÇ ÆíÀǼº Çâ»ó Ãß¼¼·Î ÀÎÇØ °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ºÏ¹Ì°¡ ¼¼°è ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ÁÖ·Î ºÏ¹ÌÀÇ ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í ³ôÀº ¾Ï ¹ßº´·ü¿¡ ±âÀÎÇÕ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÌ´Â Áö¿ªÀ¸·Î, ¾Ï ¹ßº´·ü Áõ°¡, ÀÇ·á Á¢±Ù¼º Çâ»ó, Áß±¹ ¹× Àεµ µî¿¡¼­ÀÇ ¹é±Ý Á¦Á¦ »ç¿ë Áõ°¡ µîÀÌ ±× ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ¼¼°è ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå : À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå : ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå : À¯Åë ä³Îº°

Á¦8Àå ¼¼°èÀÇ ¹é±Ý ±â¹Ý Ç×¾ÏÁ¦ ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global platinum-based cancer drugs market size is expected to reach USD 2,733.24 million by 2034, according to a new study by Polaris Market Research. The report "Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Cisplatin, Oxaliplatin, Carboplatin, and Others), Application, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle, East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of various cancers, such as ovarian, lung, and colorectal cancer, that require effective chemotherapy treatments drives the platinum-based cancer drugs market growth. Key market growth drivers include the continued effectiveness of platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin in treating solid tumors and advancements in combination therapies and personalized medicine that enhance treatment outcomes. Opportunities exist in emerging markets where access to cancer treatments is expanding, as well as in the development of new drug formulations aimed at reducing side effects and improving drug delivery.

A few platinum-based cancer drugs market trends such as the rise of combination therapies, the focus on reducing toxicity, and the growing availability of generic platinum drugs would contribute to the market's overall expansion during the forecast period. As research progresses and new applications for platinum-based drugs are explored, the market is poised for continued growth, addressing both the demand for better cancer treatments and the need for affordable therapies worldwide.

Platinum-Based Cancer Drugs Market Report Highlights

Based on type, the Cisplatin segment dominates the platinum-based cancer drugs market share due to its long-standing use and effectiveness in treating various cancers, including ovarian and testicular cancer. However, the oxaliplatin segment is the fastest-growing, driven by its increasing application in colorectal cancer treatments and combination therapies.

The ovarian cancer segment, by application, holds the largest market share, owing to the high efficacy of platinum-based drugs such as cisplatin and carboplatin in treating this cancer. Lung cancer is the fastest-growing segment, primarily due to the rising incidence of non-small cell lung cancer and the use of platinum-based therapies in combination with other drugs.

By distribution channel, the hospital-based pharmacies segment dominates the market as they are the primary providers of chemotherapy drugs, including platinum-based treatments, for inpatient care and cancer treatments. Online pharmacies are experiencing the highest growth, driven by the increasing trend of remote healthcare and patient convenience for prescription refills and outpatient treatments.

North America holds the largest share of the global market, largely due to advanced healthcare infrastructure and high cancer incidence rates in the region. Asia Pacific is the highest-growing region, fueled by the increasing cancer burden, improving healthcare access, and rising adoption of platinum-based therapies in countries such as China and India.

Polaris Market Research has segmented the platinum-based cancer drugs market report on the basis of type, application, distribution channel, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

By Application Outlook (Revenue - USD Million, 2020-2034)

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

By Regional Outlook (Revenue - USD Million, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Platinum-Based Cancer Drugs Market Insights

5. Global Platinum-Based Cancer Drugs Market, by Type

6. Global Platinum-Based Cancer Drugs Market, by Application

7. Global Platinum-Based Cancer Drugs Market, by Distribution Channel

8. Global Platinum-Based Cancer Drugs Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â